It had been more than ten days since Nova Technologies posted the announcement on LucidNet, informing the world that the off-world clinical trial commencement had been pushed forward.
They had promised to post a volunteer selection announcement within twelve days, but nothing had been posted yet.
The silence wasn't surprising at this point. Nova Technologies operated on their own timeline and had demonstrated that repeatedly. But the waiting produced its own particular kind of tension — not the explosive frustration of the first days after the nanite announcement, but something quieter and more focused. People were paying attention, checking for updates, and filling the silence with speculation.
